Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure: A Systematic Review and Meta-analysis: : Vol 0, No 0

Null

Background: Randomized controlled trials established the cardiac protection of sodium–glucose cotransporter-2 (SGLT2) inhibitors among adults with type 2 diabetes. New evidence suggests that these results could extend to people without diabetes. Purpose: To evaluate the effect of SGLT2 inhibitors in patients with heart failure, regardless of the presence of type 2 diabetes. Data Sources: Pu...

Read Complete Article

Post a Comment

Previous Post Next Post